KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Notes Payables (2017 - 2024)

Zoetis (ZTS) has disclosed Notes Payables for 7 consecutive years, with $24.0 million as the latest value for Q1 2024.

  • Quarterly Notes Payables rose 700.0% to $24.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Mar 2024, up 700.0% year-over-year, with the annual reading at $3.0 million for FY2023, 50.0% up from the prior year.
  • Notes Payables for Q1 2024 was $24.0 million at Zoetis, up from $3.0 million in the prior quarter.
  • The five-year high for Notes Payables was $24.0 million in Q1 2024, with the low at $1.0 million in Q2 2020.
  • Average Notes Payables over 5 years is $4.2 million, with a median of $3.0 million recorded in 2022.
  • The sharpest move saw Notes Payables plummeted 50.0% in 2022, then skyrocketed 700.0% in 2024.
  • Over 5 years, Notes Payables stood at $4.0 million in 2020, then changed by 0.0% to $4.0 million in 2021, then tumbled by 50.0% to $2.0 million in 2022, then surged by 50.0% to $3.0 million in 2023, then surged by 700.0% to $24.0 million in 2024.
  • According to Business Quant data, Notes Payables over the past three periods came in at $24.0 million, $3.0 million, and $2.0 million for Q1 2024, Q4 2023, and Q3 2023 respectively.